Compare Hims and Hers Health Inc (HIMS) vs State Street PDR S&P Retail ETF (XRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs State Street PDR S&P Retail ETF — how do they compare? Hims and Hers Health Inc trades at $31.09 (market cap $6.55B), while State Street PDR S&P Retail ETF trades at $84.12 (market cap $389.66M). The key difference: Hims and Hers Health Inc is far larger — about 16.8× State Street PDR S&P Retail ETF's market cap, and State Street PDR S&P Retail ETF is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and State Street PDR S&P Retail ETF for 45 Days on average.
| HIMS | XRT | |
|---|---|---|
Market Cap | $6.55B | $389.66M |
Volume | 14,842,814 | 4,275,820 |
Sector | Health | Broad Market / Factor |
52-Week High | $62.76 | $92.35 |
52-Week Low | $14.52 | $77.28 |
Typical Hold Time | 21 Days | 45 Days |
Enterprise Value | $7.25B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $30.12, up 1.96% on the day, amid a bearish technical outlook and mixed fundamentals. The stock faces headwinds from a securities class action lawsuit related to an FTC complaint, with multiple law firms alerting investors ahead of a November 2, 2026 deadline. Financially, revenue grew to $2.35 billion in 2025, but net income turned negative in 2026, with a net loss of $142 million and a profit margin of -5.51%. Analyst consensus is a 'Hold' with a $32.17 price target, indicating limited upside from current levels.
The outlook for HIMS is cautious due to legal overhangs and profitability challenges. Investment opportunities hinge on resolving regulatory issues and returning to earnings growth, but risks include prolonged litigation, competitive pressures, and execution missteps. The stock's high valuation multiples, such as a P/E of 57.14, add vulnerability if growth disappoints.
XRT trades at $84.09, up 1.42% with a bullish technical signal despite mixed moving averages and oscillators. The ETF faces headwinds from higher interest rates and inflation impacting consumer sentiment, with Seeking Alpha noting underperformance against IVV YTD. Recent retail sales data shows volatility, with August rebounding 1.2% after July's unexpected 0.6% decline. The holiday season projection of $1 trillion in sales provides potential upside catalyst.
The retail ETF's outlook remains challenged by macroeconomic pressures, though selective consumer spending and potential Fed easing could support recovery. Key risks include persistent inflation and interest rate sensitivity, while technical support at $81-83 levels provides near-term stability. Analyst sentiment appears cautious given the unsupportive macro environment heading into 2027.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About State Street PDR S&P Retail ETF
XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →
